Exact Sciences
Exact Sciences Corporation, headquartered in Madison, Wisconsin, specializes in cancer screening and diagnostic tests, both in the United States and internationally. The company is best known for Cologuard, a non-invasive stool-based DNA test designed to detect colorectal cancer and pre-cancer. Additionally, Exact Sciences offers Oncotype DX, a suite of gene expression tests that assess recurrence risk and chemotherapy benefits for breast, prostate, and colon cancers. The company is actively developing liquid biopsy tests aimed at improving cancer detection and monitoring, including tests for molecular residual disease and additional cancers. Exact Sciences holds exclusive intellectual property for its screening technology, which is recognized in the colorectal cancer screening guidelines of leading medical organizations.
Kenosha Community Health Center provides medical services and rehabilitation. Their medical services include serving children from birth to adolescence, providing immunizations, screenings, and regular well-child checkups, including preventative exams and education for parents. They provide behavioral screenings and interventions, chronic disease management, and care coordination. They provide dental services that include general dentistry, fillings, root canals, and much more. In addition, they provide pharmacy services.
Advocates for Community Wellness is a faith-based health promotion and disease prevention ministry without walls and is a nonprofit local community organization.
The company primarily operates in the Clinics/Outpatient Services industry. Erie Family Health Center was founded in 1991 and is headquartered in Chicago, IL. Similar Companies include Near North Health Service and University of Illinois Hospital and Health Sciences System.
R.L. Jones Community Outreach Center focuses on assisting those in need.
Armune BioScience, Inc. is a medical diagnostics company based in Kalamazoo, Michigan, focused on developing and commercializing blood tests that utilize the immune system's responses to detect cancer early. Founded in 2007 by members of the Apjohn Group, the company specializes in diagnostic and prognostic tests for prostate, lung, and breast cancers, facilitating personalized treatment decisions for patients and physicians. Its flagship product, APIFINY, is a cancer-specific blood test that assesses the risk of prostate cancer by measuring immune-related biological markers, and is utilized by primary care physicians, urologists, and oncologists. Armune BioScience operates through direct sales to healthcare providers and authorized representatives and has secured exclusive licensing of its technology from the University of Michigan, based on significant research published in reputable medical journals. As of December 2023, Armune operates as a subsidiary of Exact Sciences Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.